4
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Histochemical and Biochemical Investigation of Advanced Prostatic Carcinoma Treated with Estramustine Phosphate, Estracyt

&
Pages 18-22 | Received 29 Mar 1972, Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Gösta Jönsson, Bertil Högberg & Torgny Nilsson. (1977) Treatment of Advanced Prostatic Carcinoma with Estramustine Phosphate (Estracyt®). Scandinavian Journal of Urology and Nephrology 11:3, pages 231-238.
Read now
Torgny Nilsson & Jonas Müntzing. (1975) The Prognostic Value of Acid Phosphatase and β-Glucuronidase Activity in Biopsy Specimens from Patients with Reactivated Prostatic Cancer. Scandinavian Journal of Urology and Nephrology 9:3, pages 205-207.
Read now

Articles from other publishers (14)

Zhiyan Xiao, Susan L. Morris-Natschke & Kuo-Hsiung Lee. (2016) Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates. Medicinal Research Reviews 36:1, pages 32-91.
Crossref
Pijus Saha, Chhanda Debnath & Gervais Bérubé. (2013) Steroid-linked nitrogen mustards as potential anticancer therapeutics: A review. The Journal of Steroid Biochemistry and Molecular Biology 137, pages 271-300.
Crossref
D. DAPONTE, R. SYLVESTER, M. DE PAUW, A. FRYSZMAN, R. M. SMITH & P. H. SMITH. (2008) Change in White Cell Count during Treatment of Advanced Cancer of the Prostate with Estramustine Phosphate and with Stilboestrol. British Journal of Urology 55:4, pages 408-412.
Crossref
E.K. Muechler & D. Kohler. (1979) Interaction of the cytotoxic agent estramustine phosphate (Estracyt) with the estrogen receptor of the human uterus. Gynecologic Oncology 8:3, pages 330-338.
Crossref
Jonas Muntzing, Rashad Y. Kirdani, Jack Saroff, Gerald P. Murphy & Avery A. Sandberg. (1977) Inhibitory effects of estracyt on R-3327 rat prostatic carcinoma. Urology 10:5, pages 439-445.
Crossref
Guy Leclercq, Jean-Claude Heuson & Marie-Christine Deboel. (1976) Estrogen receptors interaction with Estracyt and degradation products, a biochemical study on a potential agent in the treatment of breast cancer. European Journal of Drug Metabolism and Pharmacokinetics 1:2, pages 77-84.
Crossref
G.D. Chisholm & E.P.N. O'Donoghue. 1976. 377 397 .
J.G. Forsberg & P.A. Høisaeter. 1976. 137 154 .
F. Balogh & L. Kisbenedek. (1975) Treatment of prostatic cancer with estracyt® (estramustine phosphate). International Urology and Nephrology 7:2, pages 135-140.
Crossref
Joseph D. Schmidt. (1975) Chemotherapy of Prostatic Cancer. Urologic Clinics of North America 2:1, pages 185-196.
Crossref
Martin I. Resnick & John T. Grayhack. (1975) Treatment of Stage IV Carcinoma of the Prostate. Urologic Clinics of North America 2:1, pages 141-161.
Crossref
Z. Szenddrői, I. Könyves, L. Szendi, S. Eckhardt & F. Hartay. (1974) Estracyt in hormone-resistant prostatic carcinoma. International Urology and Nephrology 6:2, pages 101-110.
Crossref
G. D. Chisholm. 1974. The Treatment of Prostatic Hypertrophy and Neoplasia. The Treatment of Prostatic Hypertrophy and Neoplasia 121 146 .
T. Nilsson & J. Müntzing. (2006) Some biochemical and histochemical aspects in hyperplasia and carcinoma of the human prostate. Journal of Surgical Oncology 5:3, pages 205-214.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.